Amends the Illinois State Auditing Act. Provides that, as soon as practical after the effective date of the amendatory Act, the Auditor General shall conduct a comprehensive investigation of how 340B covered entities within Illinois participate in the 340B Drug Discount Program. Provides that the investigation shall examine the impact of this participation by 340B covered entities on State health programs, such as Medicaid and the State Employees Group Insurance Program, and shall include the specified assessments. Requires the Auditor General to make recommendations to the General Assembly based on the findings from the investigation.
House Committee Amendment No. 1: Replaces everything after the enacting clause. Creates the 340B Transparency, Reporting, and Accountability Act. As soon as practical after the effective date of the Act, requires the Department of Insurance to conduct a comprehensive study of how 340B covered entities within Illinois participate in the 340B Drug Discount Program. Grants the Department of Insurance rulemaking authority to implement the study. Requires insurers, pharmacy benefit managers, third-party administrators, and administrative service organizations of the State Employees Group Insurance Program to comply with requests for relevant information from the Department of Insurance, subject to enforcement by the Department. Establishes the Vulnerable Community Hospital Capital Investment Fund, and provides that fines collected by the Department for failures to comply with information requests shall be deposited into the Fund. Sets forth provisions concerning confidentiality of submitted information and reporting requirements for the Department. Provides that the Act is repealed on July 1, 2029. Provides that, if and only if House Bill 2371 of the 104th General Assembly becomes law, then the Patient Access to Pharmacy Protection Act is amended by changing provisions concerning enforcement. Amends the State Finance Act to make a conforming change. Effective immediately, except that the Act does not take effect at all unless House Bill 2371 of the 104th General Assembly, as amended by Senate Amendment No. 2, becomes law.
House Floor Amendment No. 2: Replaces everything after the enacting clause. Creates the 340B Transparency, Reporting, and Accountability Act. As soon as practical after the effective date of the Act, requires the Department of Insurance to conduct a comprehensive study of how 340B covered entities and pharmaceutical manufacturers within Illinois participate in the 340B Drug Discount Program. Grants the Department of Insurance rulemaking authority to implement the study. Requires insurers, pharmacy benefit managers, third-party administrators, pharmaceutical manufacturers doing business in the State of Illinois, and administrative service organizations of the State Employees Group Insurance Program to comply with requests for relevant information from the Department of Insurance, subject to enforcement by the Department. Establishes the Vulnerable Community Hospital Capital Investment Fund, and provides that fines collected by the Department for failures to comply with information requests shall be deposited into the Fund. Sets forth provisions concerning confidentiality of submitted information and reporting requirements for the Department. Provides that the Act is repealed on July 1, 2032. Provides that, if and only if House Bill 2371 of the 104th General Assembly becomes law, then the Patient Access to Pharmacy Protection Act is amended by changing provisions concerning enforcement. Amends the State Finance Act to make a conforming change. Effective immediately, except the provisions amending the Patient Access to Pharmacy Protection Act do not take effect at all unless House Bill 2371 of the 104th General Assembly, as amended by Senate Amendment No. 2, becomes law.
House Floor Amendment No. 3: Corrects a cross-reference in provisions concerning reporting requirements.
Senate Committee Amendment No. 1: Replaces everything after the enacting clause. Reinserts the provisions of the engrossed bill with the following changes. Makes changes to defined terms and the required information that must be studied by the Department of Insurance under the 340B Drug Discount Program study. Provides that all 340 covered entities, and pharmaceutical manufacturers doing business in the State of Illinois (rather than all 340B covered entities, insurers as defined in a provision of the Illinois Insurance Code, pharmacy benefit managers, third-party administrators, pharmaceutical manufacturers doing business in the State of Illinois, and administrative service organizations of the State Employees Group Insurance Program), shall comply with requests for information relevant to the study. Makes changes to penalty provisions. Establishes severability provisions. Effective immediately or on the effective date of House Bill 2371 of the 104th General Assembly, as amended by Senate Amendment No. 2, whichever is later; however, the Act does not take effect at all unless House Bill 2371 of the 104th General Assembly, as amended by Senate Amendment No. 2, becomes law.

Statutes affected:
Introduced: 30 ILCS 5/3
Engrossed: 30 ILCS 105/5
Enrolled: 30 ILCS 105/5